Lazard Asset Management LLC Organogenesis Holdings Inc. Transaction History
Lazard Asset Management LLC
- $61.8 Billion
- Q4 2024
A detailed history of Lazard Asset Management LLC transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 171,694 shares of ORGO stock, worth $551,137. This represents 0.0% of its overall portfolio holdings.
Number of Shares
171,694
Previous 77,180
122.46%
Holding current value
$551,137
Previous $220,000
149.55%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding ORGO
# of Institutions
124Shares Held
62MCall Options Held
4.3KPut Options Held
3.9K-
Soleus Capital Management, L.P. Greenwich, CT12.5MShares$40.1 Million2.78% of portfolio
-
Morgan Stanley New York, NY11.8MShares$38 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$16.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.59MShares$11.5 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA3.08MShares$9.9 Million0.03% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $420M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...